Unveiling New Binding Sites and Allosteric Regulation Mechanisms of LSD1 for Novel Therapeutics
- 16 May 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (11) , 12125-12135
Abstract
Lysine-specific demethylase 1 (LSD1) regulates key cellular processes through both demethylase-dependent and -independent functions. Current clinical LSD1 inhibitors target its demethylase functions, and issues like the inability to fully modulate LSD1's demethylase-independent functions have limited their clinical efficacy. SP2509, an allosteric LSD1 inhibitor, can affect both demethylase-dependent and -independent functions of LSD1. Understanding the allosteric regulation mechanisms of SP2509 may facilitate the development of new LSD1 inhibitors. Using SP2509 as a probe, two new binding modes are identified in this work, both of which can alter the conformation of substrate binding pocket, effectively blocking H3 substrate binding and inhibiting the demethylase activity. Interestingly, one binding mode induces significant allosteric bending of Tower/CoREST domain, disrupting the nucleosome substrate binding─an effect not previously reported. This unique binding mode is also validated through in vitro biochemical characterizations. These findings provide invaluable structural insights for designing next-generation LSD1 inhibitors for novel therapeutics.Keywords
Funding Information
- Natural Science Foundation of Henan Province (242301420005, 252300421142, 252300421243)
- National Natural Science Foundation of China (22277110, 32371317, 82473761)
- Chunhui Project Foundation of the Education Department of China (HZKY20220280)
- Key Research and Development Project in Henan Province (241111114200, 25ZX001)
This publication has 49 references indexed in Scilit:
- Unravelling the target landscape of tranylcypromines for new drug discoveryActa Pharmaceutica Sinica B, 2025
- Strategies that regulate LSD1 for novel therapeuticsActa Pharmaceutica Sinica B, 2024
- Tranylcypromine (TCP)2023
- Recent advances of LSD1/KDM1A inhibitors for disease therapyBioorganic Chemistry, 2023
- The scaffolding function of LSD1/KDM1A reinforces a negative feedback loop to repress stem cell gene expression during primitive hematopoiesisiScience, 2022
- Repurposing antidepressants for anticancer drug discoveryDrug Discovery Today, 2022
- Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021European Journal of Medicinal Chemistry, 2022
- A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLCCancer Cell, 2015
- Structural Basis for CoREST-Dependent Demethylation of Nucleosomes by the Human LSD1 Histone DemethylaseMolecular Cell, 2006
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004